ARTICLE | Company News
AmorChem, Universit de Montreal deal
April 29, 2013 7:00 AM UTC
Life science VC fund AmorChem and the university's Univalor commercialization arm partnered to discover and develop drugs against abhydrolase domain containing 6 (ABHD6) to treat Type II diabetes. Am...